Philippines Biosimilars Market (2024-2030) Outlook | Trends, Industry, Size, Revenue, Value, Share, Growth, Forecast, Companies & Analysis

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069948 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Philippines Biosimilars Market Synopsis

The Philippines biosimilars market is expected to witness a significant growth in the coming years, driven by growing demand for cost-effective biopharmaceuticals. The increasing prevalence of chronic and lifestyle disorders such as cancer, diabetes, cardiovascular diseases and arthritis across the country are likely to drive the demand for biosimilar drugs over the forecast period. Additionally, rising investments from government authorities towards expanding healthcare infrastructure and improving accessibility of affordable medicines will be another key factor fuelling market expansion. Moreover, technological advancements in biologics manufacturing processes are projected to create lucrative opportunities for players operating in this space

Key Trends of the Market

Growing collaborations between research organizations and drug manufacturers is anticipated to spur income prospects within the industry over time. Additionally, an Increasing investment from leading pharmaceutical companies towards developing innovative therapies using advanced biological techniques is one of the major trends propelling market advancemenet. Further, the emergence of novel delivery systems such as self-administered injectables/inhalers designed specifically for patient convenience has been gaining traction lately and this trend is expected to continue during 2020-2025 timeline.

Key Growth Drivers of the Market

Key Challenges Faced by the Market

High costs associated with development & production process inhibits widespread availability particularly among low income population limit potential customer base restraining sales proportions eventually hampering entire industry progress rate adversely

Key Players of The Market

Major players operating in Philippine biosimilars market include Pfizer Inc., Amgen Inc., Sandoz (Novartis AG), Biocon Ltd., Intas Pharmaceuticals Limited , Reliance Life Sciences Pvt Ltd etc

Key Highlights of the Report:

  • Philippines Biosimilars Market Outlook
  • Market Size of Philippines Biosimilars Market, 2020
  • Forecast of Philippines Biosimilars Market, 2027
  • Historical Data and Forecast of Philippines Biosimilars Revenues & Volume for the Period 2023 - 2027
  • Philippines Biosimilars Market Trend Evolution
  • Philippines Biosimilars Market Drivers and Challenges
  • Philippines Biosimilars Price Trends
  • Philippines Biosimilars Porter's Five Forces
  • Philippines Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
  • Historical Data and Forecast of Philippines Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
  • Philippines Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • Philippines Biosimilars Top Companies Market Share
  • Philippines Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • Philippines Biosimilars Company Profiles
  • Philippines Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Philippines Biosimilars Market Overview

3.1 Philippines Country Macro Economic Indicators

3.2 Philippines Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 Philippines Biosimilars Market - Industry Life Cycle

3.4 Philippines Biosimilars Market - Porter's Five Forces

3.5 Philippines Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Philippines Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 Philippines Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 Philippines Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Philippines Biosimilars Market Trends

6 Philippines Biosimilars Market, By Types

6.1 Philippines Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 Philippines Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Philippines Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 Philippines Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 Philippines Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 Philippines Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 Philippines Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 Philippines Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Philippines Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Philippines Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 Philippines Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 Philippines Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 Philippines Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 Philippines Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 Philippines Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 Philippines Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 Philippines Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 Philippines Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 Philippines Biosimilars Market Import-Export Trade Statistics

7.1 Philippines Biosimilars Market Export to Major Countries

7.2 Philippines Biosimilars Market Imports from Major Countries

8 Philippines Biosimilars Market Key Performance Indicators

9 Philippines Biosimilars Market - Opportunity Assessment

9.1 Philippines Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Philippines Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 Philippines Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 Philippines Biosimilars Market - Competitive Landscape

10.1 Philippines Biosimilars Market Revenue Share, By Companies, 2020

10.2 Philippines Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All